Azeliragon
id:
azeliragon-185-14510128
title:
Azeliragon
text:
Azeliragon is a small-molecule RAGE inhibitor. It is developed by vTv Therapeutics for various cancers, including triple-negative breast cancer, pancreatic cancer. The chemical reached Phase III trials in slowing cognitive deterioration in early stage Alzheimer's disease patients. It was also tested in people with diabetic neuropathy and animal models of graft-vs-host disease.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Azeliragon
date created:
2023-12-02T04:30:17Z
date modified:
2024-09-07T19:53:18Z
main entity:
{"identifier":"Q27074825","url":"https://www.wikidata.org/entity/Q27074825"}
image:
fields total:
13
integrity:
15